|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 202.05 INR | +0.37% |
|
-8.16% | -2.93% |
| Feb. 13 | Ruchira Papers Limited Announces Board and Committee Changes, Effective January 23 2026 | CI |
| Feb. 06 | Viyash Scientific Limited, Q3 2026 Earnings Call, Feb 06, 2026 |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Veterinary Drugs | ||||||||||
Pharmaceuticals | 13.62B | 14.13B | 14.21B | 13.7B | 15.51B | |||||
Total Assets | 13.93B | 14.41B | 15.29B | 15.4B | 16.02B | |||||
Interest Expense | -193M | -135M | -297M | -464M | -560M | |||||
Income Tax Expense | 322M | 83.26M | -157M | -250M | 120M | |||||
CAPEX | -528M | -325M | -862M | -308M | -391M | |||||
EBT | 1.37B | 534M | -1.38B | -546M | 443M | |||||
D&A | 475M | 477M | 535M | 598M | 643M | |||||
Operating Income | - | - | - | - | - | |||||
Net Income | 954M | 413M | -1.21B | -359M | 219M | |||||
Pharmaceutical Products | ||||||||||
Total Assets | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
Life Sciences Tools and Services | ||||||||||
Analytical Services | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - |
Geographical Revenue Distribution History
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Europe | 6.25B | 5.94B | 5.76B | 5.72B | 7B | |||||
Total Assets | 5.21B | 4.88B | 4.16B | 3.58B | 5.11B | |||||
CAPEX | -111M | -147M | -70K | -94.94M | -185M | |||||
Asia | 3.89B | 3.9B | 4.76B | 3.3B | 4.45B | |||||
Total Assets | 6.33B | 6.41B | 6.68B | 7.39B | 6.44B | |||||
CAPEX | -418M | -183M | -710M | -266M | -356M | |||||
Rest of the World | 3.48B | 4.29B | 3.69B | 4.68B | 4.06B | |||||
Total Assets | 1.32B | 2.35B | 3.84B | 3.51B | 3.34B | |||||
CAPEX | -6.23M | -12.64M | -63.14M | -20.87M | -12.62M | |||||
Total Assets | 1.07B | 775M | 613M | 927M | 1.13B | |||||
Total Assets | - | - | - | - | - |
- Stock Market
- Equities
- VIYASH Stock
- Financials Viyash Scientific Limited
- Business Segments
Select your edition
All financial news and data tailored to specific country editions
